Skip to main content

Animations

MJFF Publications

4601 - 4610 of 6295 Results
Title
Year
  • Year
  • 2022
  • 2016
  • 2020
  • 2023
  • 2014
  • 2023
  • 2021
  • 2018
  • 2017
  • 2022
  • Summary Details
    OPEN
    Title: Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in protein
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00322-x
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Inflammatory profile in LRRK2-associated prodromal and clinical PD
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-016-0588-5
    Citation Count: 66
  • Summary Details
    OPEN
    Title: CoolMPS: evaluation of antibody labeling based massively parallel non-coding RNA sequencing
    Journal Name: Nucleic Acids Research
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/nar/gkaa1122
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00476-2
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011
    Citation Count: 69
  • Summary Details
    OPEN
    Title: Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-023-02585-x
    Citation Count: 18
  • Summary Details
    OPEN
    Title: Imaging mass cytometry reveals generalised deficiency in OXPHOS complexes in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-021-00182-x
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Cortical structural involvement and cognitive dysfunction in early Parkinson's disease
    Journal Name: NMR in Biomedicine
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/nbm.3900
    Citation Count: 8
  • Summary Details
    OPEN
    Title: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awx378
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Tumor suppressor PALB2 maintains redox and mitochondrial homeostasis in the brain and cooperates with ATG7/autophagy to suppress neurodegeneration
    Journal Name: PLOS Genetics
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pgen.1010138
    Citation Count: 8
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.